Christopher A Arger1,2,3, Taraneh Taghavi4, Sarah H Heil1,2,3, Joan Skelly1, Rachel F Tyndale4,5,6, Stephen T Higgins1,2,3. 1. Tobacco Center on Regulatory Science, Vermont Center on Behavior and Health, Larner College of Medicine, University of Vermont, Burlington, VT. 2. Department of Psychological Science, College of Arts and Science, University of Vermont, Burlington, VT. 3. Department of Psychiatry, Larner College of Medicine, University of Vermont, Burlington, VT. 4. Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON. 5. Department of Psychiatry, University of Toronto, Toronto, ON. 6. Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, Toronto, ON.
Abstract
INTRODUCTION: Pregnancy-induced increases in nicotine metabolism may contribute to difficulties in quitting smoking during pregnancy. However, the time course of changes in nicotine metabolism during early and late pregnancy is unclear. This study investigated how pregnancy alters the nicotine metabolite ratio (NMR), a common biomarker of nicotine metabolism among nonpregnant smokers. METHODS:Urinary NMR (trans-3'-hydroxycotinine [3HC]/cotinine [COT]) was assessed using total (free + glucuronide) and free compounds among women (N = 47) from a randomized controlled trial for smoking cessation who self-reported smoking and provided a urine sample during early pregnancy (M ± SD = 12.5 ± 4.5 weeks' gestation), late pregnancy (28.9 ± 2.0 weeks' gestation), and 6 months postpartum (24.7 ± 1.2 weeks since childbirth). Urine samples were analyzed using liquid chromatography-tandem mass spectrometry and NMR were calculated as Total 3HC/Free COT, Free 3HC/Free COT, and Total 3HC/Total COT. RESULTS:NMR was significantly higher during early and late pregnancy compared to postpartum and significantly increased from early to late pregnancy as measured by Total 3HC/Free COT (0.76, 0.89, 0.60; all p's < .05) and Free 3HC/Free COT (0.68, 0.80, 0.51; all p's < .05). Total 3HC/Total COT did not vary over time (p = .81). CONCLUSIONS:Total 3HC/Free COT andFree 3HC/Free COT increased in the first trimester and continued to increase throughout pregnancy, suggesting a considerable increase in nicotine metabolism over gestation. Future analyses are needed to interpret the changes in NMR in the context of nicotine pharmacokinetics, as well as its impact on changes in smoking behavior and cessation outcomes. IMPLICATIONS: We observed that the NMR was significantly higher as early as 12 weeks' gestation and increased further as a function of gestational age. Among nonpregnant smokers, elevated NMR is associated with smoking phenotypes such as smoking more cigarettes per day and poorer response to nicotine patch; therefore, pregnancy-induced increases in the NMR may contribute to smoking during the first trimester of pregnancy and reducing or quitting smoking may become more challenging as the rate of nicotine metabolism accelerates over the course of pregnancy.
RCT Entities:
INTRODUCTION: Pregnancy-induced increases in nicotine metabolism may contribute to difficulties in quitting smoking during pregnancy. However, the time course of changes in nicotine metabolism during early and late pregnancy is unclear. This study investigated how pregnancy alters the nicotine metabolite ratio (NMR), a common biomarker of nicotine metabolism among nonpregnant smokers. METHODS: Urinary NMR (trans-3'-hydroxycotinine [3HC]/cotinine [COT]) was assessed using total (free + glucuronide) and free compounds among women (N = 47) from a randomized controlled trial for smoking cessation who self-reported smoking and provided a urine sample during early pregnancy (M ± SD = 12.5 ± 4.5 weeks' gestation), late pregnancy (28.9 ± 2.0 weeks' gestation), and 6 months postpartum (24.7 ± 1.2 weeks since childbirth). Urine samples were analyzed using liquid chromatography-tandem mass spectrometry and NMR were calculated as Total 3HC/Free COT, Free 3HC/Free COT, and Total 3HC/Total COT. RESULTS: NMR was significantly higher during early and late pregnancy compared to postpartum and significantly increased from early to late pregnancy as measured by Total 3HC/Free COT (0.76, 0.89, 0.60; all p's < .05) and Free 3HC/Free COT (0.68, 0.80, 0.51; all p's < .05). Total 3HC/Total COT did not vary over time (p = .81). CONCLUSIONS: Total 3HC/Free COT and Free 3HC/Free COT increased in the first trimester and continued to increase throughout pregnancy, suggesting a considerable increase in nicotine metabolism over gestation. Future analyses are needed to interpret the changes in NMR in the context of nicotine pharmacokinetics, as well as its impact on changes in smoking behavior and cessation outcomes. IMPLICATIONS: We observed that the NMR was significantly higher as early as 12 weeks' gestation and increased further as a function of gestational age. Among nonpregnant smokers, elevated NMR is associated with smoking phenotypes such as smoking more cigarettes per day and poorer response to nicotine patch; therefore, pregnancy-induced increases in the NMR may contribute to smoking during the first trimester of pregnancy and reducing or quitting smoking may become more challenging as the rate of nicotine metabolism accelerates over the course of pregnancy.
Authors: Allison N Kurti; Ryan Redner; Alexa A Lopez; Diana R Keith; Andrea C Villanti; Cassandra A Stanton; Diann E Gaalema; Janice Y Bunn; Nathan J Doogan; Antonio Cepeda-Benito; Megan E Roberts; Julie Phillips; Stephen T Higgins Journal: Prev Med Date: 2017-08-05 Impact factor: 4.018
Authors: Andrew A Strasser; Neal L Benowitz; Angela G Pinto; Kathy Z Tang; Stephen S Hecht; Steve G Carmella; Rachel F Tyndale; Caryn E Lerman Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-01-06 Impact factor: 4.254
Authors: Jill C Mwenifumbo; Qian Zhou; Neal L Benowitz; Edward M Sellers; Rachel F Tyndale Journal: Pharmacogenomics Date: 2010-02 Impact factor: 2.533
Authors: Eleanor I Miller; Hye-Ryun K Norris; Douglas E Rollins; Stephen T Tiffany; Diana G Wilkins Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2009-12-22 Impact factor: 3.205
Authors: Meghan J Chenoweth; Maria Novalen; Larry W Hawk; Robert A Schnoll; Tony P George; Paul M Cinciripini; Caryn Lerman; Rachel F Tyndale Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-07-10 Impact factor: 4.254
Authors: Taraneh Taghavi; Christopher A Arger; Sarah H Heil; Stephen T Higgins; Rachel F Tyndale Journal: J Pharmacol Exp Ther Date: 2017-11-20 Impact factor: 4.030
Authors: Taraneh Taghavi; Christopher A Arger; Sarah H Heil; Stephen T Higgins; Rachel F Tyndale Journal: Addiction Date: 2018-07-23 Impact factor: 6.526
Authors: Laura R Stroud; George D Papandonatos; Nancy C Jao; Raymond Niaura; Stephen Buka; Neal L Benowitz Journal: Drug Alcohol Depend Date: 2022-02-17 Impact factor: 4.492
Authors: Sarah H Heil; Cecilia L Bergeria; Dustin C Lee; Janice Y Bunn; Roxanne F Harfmann; John R Hughes; Haley J Tetreault; Stephen T Higgins Journal: Prev Med Date: 2020-08-05 Impact factor: 4.018
Authors: Sulamunn R M Coleman; Janice Y Bunn; Tyler D Nighbor; Allison N Kurti; Hypatia A Bolívar; Rachel F Tyndale; Stephen T Higgins Journal: Prev Med Date: 2021-04-27 Impact factor: 4.018
Authors: Haidy K Giratallah; Meghan J Chenoweth; Newton Addo; Jasjit S Ahluwalia; Lisa Sanderson Cox; Caryn Lerman; Tony P George; Neal L Benowitz; Rachel F Tyndale Journal: Drug Alcohol Depend Date: 2021-04-20 Impact factor: 4.852
Authors: Khosbayar Lkhagvadorj; Karolin F Meyer; Laura P Verweij; Wierd Kooistra; Marjan Reinders-Luinge; Henk W Dijkhuizen; Inge A M de Graaf; Torsten Plösch; Machteld N Hylkema Journal: Epigenetics Date: 2020-06-23 Impact factor: 4.528
Authors: Parnian Kheirkhah Rahimabad; Thilani M Anthony; A Daniel Jones; Shakiba Eslamimehr; Nandini Mukherjee; Susan Ewart; John W Holloway; Hasan Arshad; Sarah Commodore; Wilfried Karmaus Journal: Int J Environ Res Public Health Date: 2020-12-20 Impact factor: 3.390